Todd E. DeFor

22.6k total citations · 4 hit papers
297 papers, 15.7k citations indexed

About

Todd E. DeFor is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Todd E. DeFor has authored 297 papers receiving a total of 15.7k indexed citations (citations by other indexed papers that have themselves been cited), including 224 papers in Hematology, 89 papers in Oncology and 61 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Todd E. DeFor's work include Hematopoietic Stem Cell Transplantation (206 papers), Acute Myeloid Leukemia Research (55 papers) and Acute Lymphoblastic Leukemia research (54 papers). Todd E. DeFor is often cited by papers focused on Hematopoietic Stem Cell Transplantation (206 papers), Acute Myeloid Leukemia Research (55 papers) and Acute Lymphoblastic Leukemia research (54 papers). Todd E. DeFor collaborates with scholars based in United States, United Kingdom and France. Todd E. DeFor's co-authors include Daniel J. Weisdorf, John E. Wagner, Bruce R. Blazar, Jeffrey S. Miller, Margaret L. MacMillan, Claudio G. Brunstein, Juliet N. Barker, Philip B. McGlave, Linda J. Burns and Stella M. Davies and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Todd E. DeFor

285 papers receiving 15.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

2005 1.4k citations Jeffrey S. Miller, Angela Panoskaltsis‐Mortari et al. Blood profile →
Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics

2010 805 citations Claudio G. Brunstein, Jeffrey S. Miller et al. Blood profile →
Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival

2002 743 citations John E. Wagner, Juliet N. Barker et al. Blood profile →
Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy

2004 597 citations Juliet N. Barker, Daniel J. Weisdorf et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Todd E. DeFor United States	62	10.1k	6.5k	5.1k	2.9k	1.8k	297	15.7k
Vincent T. Ho United States	65	10.4k 1.0×	5.8k 0.9×	3.4k 0.7×	2.1k 0.8×	2.3k 1.2×	323	14.9k
Didier Blaise France	60	12.1k 1.2×	5.1k 0.8×	5.0k 1.0×	2.1k 0.7×	3.7k 2.0×	652	16.5k
Jürgen Finke Germany	58	6.9k 0.7×	3.4k 0.5×	3.8k 0.7×	2.7k 0.9×	2.0k 1.1×	396	12.9k
Philip B. McGlave United States	54	7.9k 0.8×	5.5k 0.8×	3.8k 0.7×	2.1k 0.7×	1.5k 0.8×	160	12.4k
Marcos de Lima United States	62	9.2k 0.9×	2.9k 0.4×	3.5k 0.7×	2.3k 0.8×	2.8k 1.5×	421	12.7k
Nancy A. Kernan United States	52	7.2k 0.7×	4.0k 0.6×	2.9k 0.6×	1.4k 0.5×	1.5k 0.8×	254	10.8k
William Arcese Italy	47	8.9k 0.9×	3.0k 0.5×	2.6k 0.5×	2.6k 0.9×	2.1k 1.2×	257	11.0k
Roel Willemze Netherlands	59	7.3k 0.7×	5.4k 0.8×	3.9k 0.8×	3.3k 1.1×	2.0k 1.1×	288	14.3k
Mats Remberger Sweden	52	5.9k 0.6×	2.6k 0.4×	2.4k 0.5×	3.0k 1.0×	1.2k 0.6×	243	10.0k
Steven M. Devine United States	49	6.1k 0.6×	3.0k 0.5×	3.4k 0.7×	3.1k 1.1×	1.3k 0.7×	318	11.0k

Countries citing papers authored by Todd E. DeFor

Since Specialization

Citations

This map shows the geographic impact of Todd E. DeFor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd E. DeFor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd E. DeFor more than expected).

Fields of papers citing papers by Todd E. DeFor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd E. DeFor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd E. DeFor. The network helps show where Todd E. DeFor may publish in the future.

Co-authorship network of co-authors of Todd E. DeFor

This figure shows the co-authorship network connecting the top 25 collaborators of Todd E. DeFor. A scholar is included among the top collaborators of Todd E. DeFor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd E. DeFor. Todd E. DeFor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Modi, Dipenkumar, Yosra Aljawai, Todd E. DeFor, et al.. (2025). Matched unrelated vs haploidentical donor hematopoietic cell transplantation using posttransplant cyclophosphamide. Blood Advances. 10(1). 233–245. 1 indexed citations

Al‐Homsi, A. Samer, Todd E. DeFor, Stephanie King, et al.. (2024). CAST Regimen for GvHD Prophylaxis: A CIBMTR Propensity Score-Matched Analysis. Transplantation and Cellular Therapy. 30(11). 1092–1098. 1 indexed citations

Shaffer, Brian C., Mahasweta Gooptu, Todd E. DeFor, et al.. (2024). Post-Transplant Cyclophosphamide–Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors. Journal of Clinical Oncology. 42(28). 3277–3286. 20 indexed citations

Kulkarni, Amit, Maryam Ebadi, Mohamad Aghaie Meybodi, et al.. (2020). Comparative analysis of antibiotic exposure association with clinical outcomes of chemotherapy versus immunotherapy across three tumour types. ESMO Open. 5(5). e000803–e000803. 26 indexed citations

Rashidi, Armin, Maryam Ebadi, Robin Shields‐Cutler, et al.. (2019). Early E. casseliflavus gut colonization and outcomes of allogeneic hematopoietic cell transplantation. PLoS ONE. 14(8). e0220850–e0220850. 5 indexed citations

Rashidi, Armin, Maryam Ebadi, Robin Shields‐Cutler, et al.. (2018). Pre-Engraftment Gut Colonization with Enterococcus Casseliflavus Improves Survival after Allogeneic Hematopoietic Cell Transplantation. Blood. 132(Supplement 1). 813–813.

Rashidi, Armin, Michael A. Linden, Todd E. DeFor, et al.. (2017). History of consolidation is prognostic in acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantation in minimal residual disease‐negative first complete remission. American Journal of Hematology. 92(10). 1032–1036. 15 indexed citations

Ebens, Christen L., et al.. (2017). Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia. Biology of Blood and Marrow Transplantation. 24(4). 765–771. 27 indexed citations

Bachanová, Veronika, Dhifaf Sarhan, Todd E. DeFor, et al.. (2017). Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells. Cancer Immunology Immunotherapy. 67(3). 483–494. 78 indexed citations

10.

Watanabe, Yoichi, Todd E. DeFor, Kathryn E. Dusenbery, et al.. (2016). BRAF Mutation Is Associated with Improved Local Control of Melanoma Brain Metastases Treated with Gamma Knife Radiosurgery. Frontiers in Oncology. 6. 107–107. 13 indexed citations

11.

DeFor, Todd E., et al.. (2016). MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomes. Bone Marrow Transplantation. 52(4). 532–538. 3 indexed citations

12.

Brunstein, Claudio G., Jeffrey S. Miller, David H. McKenna, et al.. (2015). Umbilical cord blood–derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect. Blood. 127(8). 1044–1051. 303 indexed citations

13.

MacMillan, Margaret L., Todd E. DeFor, Jo‐Anne H. Young, et al.. (2015). Alternative donor hematopoietic cell transplantation for Fanconi anemia. Blood. 125(24). 3798–3804. 66 indexed citations

14.

Burns, Linda J., et al.. (2013). Association of iron overload with allogeneic hematopoietic cell transplantation outcomes: a prospective cohort study using R2-MRI–measured liver iron content. Blood. 122(9). 1678–1684. 47 indexed citations

15.

Brunstein, Claudio G., Jeffrey S. Miller, Qing Cao, et al.. (2010). Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood. 117(3). 1061–1070. 805 indexed citations breakdown →

16.

Brunstein, Claudio G., Jonathan A. Gutman, Daniel J. Weisdorf, et al.. (2010). Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood. Blood. 116(22). 4693–4699. 311 indexed citations

17.

Jacobson, Pamala A., et al.. (2008). Higher Mycophenolate Dose Requirements in Children Undergoing Hematopoietic Cell Transplant (HCT). The Journal of Clinical Pharmacology. 48(4). 485–494. 17 indexed citations

18.

Brunstein, Claudio G., Juliet N. Barker, Daniel J. Weisdorf, et al.. (2007). Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood. 110(8). 3064–3070. 376 indexed citations

19.

Majhail, Navneet S., et al.. (2006). Alveolar hemorrhage following allogeneic hematopoietic cell transplantation using reduced-intensity conditioning. Bone Marrow Transplantation. 38(11). 765–768. 9 indexed citations

20.

MacMillan, Margaret L., Daniel J. Weisdorf, John E. Wagner, et al.. (2002). Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: Comparison of grading systems. Biology of Blood and Marrow Transplantation. 8(7). 387–394. 297 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact